SE427931B - Forfarande for framstellning av en pankreatisk glukagonspecifik antikropp - Google Patents

Forfarande for framstellning av en pankreatisk glukagonspecifik antikropp

Info

Publication number
SE427931B
SE427931B SE7801545A SE7801545A SE427931B SE 427931 B SE427931 B SE 427931B SE 7801545 A SE7801545 A SE 7801545A SE 7801545 A SE7801545 A SE 7801545A SE 427931 B SE427931 B SE 427931B
Authority
SE
Sweden
Prior art keywords
glucagon
antibody
pancreatic
pancreatic glucagon
gli
Prior art date
Application number
SE7801545A
Other languages
English (en)
Swedish (sv)
Other versions
SE7801545L (sv
Inventor
T Nishino
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of SE7801545L publication Critical patent/SE7801545L/xx
Publication of SE427931B publication Critical patent/SE427931B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE7801545A 1977-02-10 1978-02-09 Forfarande for framstellning av en pankreatisk glukagonspecifik antikropp SE427931B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP52013919A JPS5836308B2 (ja) 1977-02-10 1977-02-10 抗体の製造方法

Publications (2)

Publication Number Publication Date
SE7801545L SE7801545L (sv) 1978-08-11
SE427931B true SE427931B (sv) 1983-05-24

Family

ID=11846569

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801545A SE427931B (sv) 1977-02-10 1978-02-09 Forfarande for framstellning av en pankreatisk glukagonspecifik antikropp

Country Status (8)

Country Link
US (2) US4221777A (el)
JP (1) JPS5836308B2 (el)
BE (1) BE863810A (el)
DE (1) DE2805663B2 (el)
DK (1) DK157340C (el)
FR (1) FR2380296A1 (el)
GB (1) GB1580582A (el)
SE (1) SE427931B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5539702A (en) * 1978-08-30 1980-03-19 Takeda Chem Ind Ltd Method of measuring enzyme immunity of pancreas glucagon
JPS5657753A (en) * 1979-10-16 1981-05-20 Toyo Jozo Co Ltd Novel glucagon fragment, and its use
US4376765A (en) * 1980-03-31 1983-03-15 Institut International De Pathologie Cellulaire Et Moleculaire Medicaments, their preparation and compositions containing same
JPS56163456A (en) * 1980-05-21 1981-12-16 Otsuka Pharmaceut Co Ltd Preparation of antigen
DK283180A (da) * 1980-07-01 1982-01-02 Novo Industri As Polypeptider og derivater deraf
JPS5735551A (en) * 1980-08-08 1982-02-26 Daiichi Rajio Isotope Kenkyusho:Kk Preparation of undecapeptide
US4430326A (en) 1981-12-22 1984-02-07 University Patents, Inc. Method of diminishing glucose levels resulting from endogenous glucagon
FR2525592B1 (el) * 1982-04-26 1984-09-14 Pasteur Institut
US4487715A (en) * 1982-07-09 1984-12-11 The Regents Of The University Of California Method of conjugating oligopeptides
US4591552A (en) * 1982-09-29 1986-05-27 New York Blood Center, Inc. Detection of hepatitis B surface antigen (or antibody to same) with labeled synthetic peptide
EP0134868A1 (en) * 1983-08-26 1985-03-27 Anda Biologicals Unicellular organisms activated by glutaraldehyde as solid carriers for sensitizing agents and uses of sensitized unicellular organisms
CA1256795A (en) * 1983-12-28 1989-07-04 Dennis A. Carson Anti-idiotype antibodies induced by synthetic polypeptides
US4666884A (en) * 1984-04-10 1987-05-19 New England Deaconess Hospital Method of inhibiting binding of von Willebrand factor to human platelets and inducing interaction of platelets with vessel walls
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
US4731439A (en) * 1985-11-22 1988-03-15 Oncogen Snake venom growth arresting peptide
US5545618A (en) * 1990-01-24 1996-08-13 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatment
US5176227A (en) * 1991-08-01 1993-01-05 Tec Tran Corporation Railway service and parking brake actuator
US5253736A (en) * 1991-08-01 1993-10-19 Tec Tran Corporation Railway brake actuator
US20050009205A1 (en) * 2003-07-11 2005-01-13 Ye Fang Fluorescent ligands for GPCR arrays
KR20170062466A (ko) 2014-09-16 2017-06-07 리제너론 파마슈티칼스 인코포레이티드 항-글루카곤 항체 및 그것의 사용
WO2018044903A1 (en) 2016-08-30 2018-03-08 Regeneron Pharmaceuticals, Inc. Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
US20190248888A1 (en) 2016-10-20 2019-08-15 Regeneron Pharmaceuticals, Inc. Methods of lowering blood glucose levels
US20210130480A1 (en) 2017-08-22 2021-05-06 Regeneron Pharmaceuticals, Inc. Methods of treating urea cycle disorders by interfering with glucagon receptor signaling
CN114410590B (zh) * 2022-01-27 2024-01-09 广州市进德生物科技有限公司 一种分泌胰高血糖素单克隆抗体杂交瘤细胞株及其单克隆抗体与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553310A (en) * 1967-12-28 1971-01-05 Miles Lab Immunologically reactive particles
CH538003A (fr) * 1968-03-29 1973-01-31 Anvar Procédé pour l'obtention d'articles textiles porteurs d'enzymes
GB1282163A (en) * 1969-08-06 1972-07-19 Beecham Group Ltd Modified allergens and a process for their preparation
US3975342A (en) * 1972-05-15 1976-08-17 Biological Developments, Inc. Tyrosyl-class antigenic conjugates, their preparation and antibodies raised thereto
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay

Also Published As

Publication number Publication date
BE863810A (fr) 1978-05-29
DK157340B (da) 1989-12-18
GB1580582A (en) 1980-12-03
DE2805663A1 (de) 1978-08-17
FR2380296A1 (fr) 1978-09-08
DE2805663B2 (de) 1980-03-13
FR2380296B1 (el) 1981-07-10
DK59778A (da) 1978-08-11
JPS5399320A (en) 1978-08-30
DK157340C (da) 1990-05-14
US4272433A (en) 1981-06-09
JPS5836308B2 (ja) 1983-08-08
SE7801545L (sv) 1978-08-11
DE2805663C3 (el) 1980-11-13
US4221777A (en) 1980-09-09

Similar Documents

Publication Publication Date Title
SE427931B (sv) Forfarande for framstellning av en pankreatisk glukagonspecifik antikropp
Faber et al. Characterization of seven C-peptide antisera
Heding et al. Radioimmunological determination of human C-peptide in serum
US3975342A (en) Tyrosyl-class antigenic conjugates, their preparation and antibodies raised thereto
FABER et al. Production of antisera to synthetic benzyloxycarbonyl-C-peptide of human proinsulin
US4478744A (en) Method of obtaining antibodies
Aston et al. Monoclonal antibodies to growth hormone and prolactin
JP2939439B2 (ja) 膵島アミロイドポリペプチドに対する抗体
SE454301B (sv) Forfarande for framstellning av tarmglukagonantigen och motsvarande antikropp
FI95579B (fi) Immunologinen menetelmä intaktin prokollageenipeptidin (tyyppi III) ja prokollageenin (tyyppi III) määrittämiseksi selektiivisesti elimistönesteistä ja väline sen toteuttamiseksi
US5955582A (en) Antibody against a 3-aminophenylboronic-glycated protein complex and its use in an immunoassay
Ardill 2 Radioimmunoassay of GI hormones
JP3174041B2 (ja) 抗ヒト絨毛性性腺刺激ホルモン（ｈＣＧ）抗体
Kessler et al. Monoclonal antibodies that specifically recognize crystals of dinitrobenzene
Kumar et al. Measurement of Serum C-peptide Immunoreactlvlty by Radioimmunoassay in Insulin-dependent Diabetics
Soybel et al. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies
Iwasaki et al. Radioimmunoassay of neurotensin and the distribution and concentration of gut neurotensin in rat and dog
US5514599A (en) Antibodies against highly conserved amino acid sequences of insulin a process for the preparation of these antibodies and the use thereof in immunoassays
Heding Radioimmunoassays for insulin, C-peptide and proinsulin
JP2715187B2 (ja) ＰＴＨｒＰの免疫学的測定方法
JP4602488B2 (ja) 抗血清およびその製造方法
JPH09178742A (ja) 肺小細胞癌検出薬及びその使用
JPS6114465B2 (el)
Shahani et al. Raising of antisera to protein hormones without using Freund's adjuvant
CN117362432A (zh) C肽重组兔单克隆抗体、制备方法及其应用

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7801545-0

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7801545-0

Format of ref document f/p: F